Two studies have reported that overexpression of PRMT5 promoted the proliferative, migratory, and colony-forming abilities of CRC cells, but when PRMT5 was knocked down, pharmacological inhibition had the opposite effect. Here, PRMT5 is linked to colorectal carcinoma.